BPC-157 and PE-22-28 Interaction

Compatible
Researched 90% confidence

BPC-157 and PE-22-28 have a compatible interaction with 90% confidence. Different mechanisms, no contraindications. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

PE-22-28

TREK-1 Channel Blocker | Shortened Spadin Analog

Selectively blocks TREK-1 potassium channels (IC50: 0.12 nM).

Half-life: Approximately 23 hours Typical dose: 50-200mcg daily cognitive, longevity
serotonin receptor serotonergicteratogenic
View full profile

Combined Organ Load

Blood Vessels
low
Brain
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (BPC-157, PE-22-28). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with PE-22-28?

Yes, BPC-157 and PE-22-28 can generally be taken together. Different mechanisms, no contraindications.

Is BPC-157 and PE-22-28 safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and PE-22-28?

Different mechanisms, no contraindications. This assessment has 90% confidence and is based on documented research data.

How should I time BPC-157 and PE-22-28?

BPC-157 has a half-life of <30 minutes and PE-22-28 has a half-life of Approximately 23 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs PE-22-28

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.